Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN117209449B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ligand-free CuCl catalyzed trifluoromethylation method offers cost reduction and scalable production for pharmaceutical intermediates supply chain.
Novel ligand-free CuCl catalyzed method offers high selectivity and scale-up potential for pharmaceutical intermediates reducing cost and improving supply chain reliability significantly.